1. Home
  2. GRF vs YI Comparison

GRF vs YI Comparison

Compare GRF & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Capital Growth Fund Inc.

GRF

Eagle Capital Growth Fund Inc.

HOLD

Current Price

$10.97

Market Cap

42.5M

Sector

Finance

ML Signal

HOLD

Logo 111 Inc.

YI

111 Inc.

HOLD

Current Price

$5.33

Market Cap

49.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRF
YI
Founded
1989
2010
Country
United States
China
Employees
N/A
N/A
Industry
Finance/Investors Services
Retail-Drug Stores and Proprietary Stores
Sector
Finance
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
42.5M
49.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GRF
YI
Price
$10.97
$5.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.0K
69.1K
Earning Date
01-01-0001
12-17-2025
Dividend Yield
3.70%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
N/A
$1,908,028,152.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.93
$2.48
52 Week High
$10.19
$11.35

Technical Indicators

Market Signals
Indicator
GRF
YI
Relative Strength Index (RSI) 53.98 68.79
Support Level $10.36 $4.79
Resistance Level $11.05 $6.86
Average True Range (ATR) 0.18 0.66
MACD -0.02 0.26
Stochastic Oscillator 49.75 66.21

Price Performance

Historical Comparison
GRF
YI

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: